Blackstone Inc’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,616,290
Closed -$27.6M 310
2025
Q3
$27.6M Sell
1,616,290
-40,500
-2% -$580K 0.11% 62
2025
Q2
$20.8M Buy
1,656,790
+274,203
+20% +$3.27M 0.09% 66
2025
Q1
$16.5M Buy
1,382,587
+812,872
+143% +$11.1M 0.07% 65
2024
Q4
$8.34M Buy
569,715
+544,633
+2,171% +$7.62M 0.04% 81
2024
Q3
$315K Buy
+25,082
New +$273K ﹤0.01% 149

Other funds holding ZYME

Blackstone Inc's ZYME Position: Q4 2025 in Review

Blackstone Inc sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 1,616,290 shares — an estimated $27.6M sold.

Blackstone Inc first reported a position in ZYME in Q3 2024 and held it in 5 quarters. The position peaked at $27.6M in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Blackstone Inc reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Blackstone Inc sold 1,616,290 Zymeworks shares in Q4 2025, an estimated $27.6M.
  • Blackstone Inc first reported a position in Zymeworks in Q3 2024 and held it in 5 quarters.
  • Blackstone Inc's Zymeworks position peaked at $27.6M in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.